- $3.98bn
- $3.76bn
- $582.01m
- 97
- 26
- 89
- 82
Annual income statement for Exponent, fiscal year end - January 2nd, USD millions except per share, conversion factor applied.
2021 January 1st | 2022 December 30th | 2023 December 29th | 2025 January 3rd | 2026 January 2nd | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 53 W | 52 W |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 400 | 513 | 537 | 559 | 582 |
| Cost of Revenue | |||||
| Gross Profit | 378 | 464 | 497 | 518 | 537 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 317 | 372 | 425 | 439 | 462 |
| Operating Profit | 83.2 | 141 | 111 | 120 | 120 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 96.9 | 132 | 136 | 147 | 147 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 82.6 | 102 | 100 | 109 | 106 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 82.6 | 102 | 100 | 109 | 106 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 82.6 | 102 | 100 | 109 | 106 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.55 | 1.96 | 1.94 | 2.11 | 2.07 |
| Dividends per Share |